References
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brombilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., Veronesi, U.: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N. Engl. J. Med. 294, 405–410 (1976)
Bonadonna, G., Rossi, A., Valagussa, P., Banfi, A., Veronesi, U.: The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer (in press)
Burnett, F. M.: Immunological surveillance in neoplasia transplant. Rev. 7, 3–25 (1971)
DeVita, V. T., Young, R. C., Canellos, G. P.: Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 35, 98–110 (1975)
Fisher, B., Ravdin, R. G., Ausman, R. K.: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann. Surg. 168, 337 (1968)
Fisher, B., Carbone, P., Economou, S. G.: L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N. Engl. J. Med. 292, 117–122 (1975)
Fisher, B., Slack, N., Katrych, D.: A 10-year follow-up of breast cancer patients in a cooperative trial. Surg. Gynecol. Obstet. 140–528 (1975)
Harris, J. W., Shan, B., Menenses, J.: Relationship between growth and radiosensitivity in the P388 murine leukemia. Cancer Res. 33, 1780–1789 (1973)
Karle, H., Ernst, P., Killman, S. A.: Changing cytokinetic patterns of human leukemic lymphoblasts during the course of the disease studied in vivo. Br. J. Haematol. 24, 231–234 (1973)
Martin, D. S., Fugmann, R. A.: Clinical implications of the interrelationship of tumor size and chemotherapeutic response. Ann. Surg. 151, 97 (1960)
Martin, D. S., Fugmann, R. A., Hayworth, P.: Surgery, cancer chemotherapy, host defences, and tumor size. J. Nat. Cancer Inst. 29, 817 (1962)
Laster, W. R., Mayo, J. G., Simpson-Herren, L.: Success and failure in the treatment of solid tumors. — II. Kinetic parameters and “cell cure” of moderately advanced carcinoma 755. Cancer Chemother. Rep. 53, 169–188 (1969)
Nissen-Meyer, R., Kjellgren, K., Marson, B.: Preliminary report from the Scandinavian Adjuvant Chemotherapy Study Group. Cancer Chemother. Rep. 55, 561 (1971)
Roosa, R., Weaver, C. F., DeLamater, E. D.: Importance of transplant size in chemotherapeutic assay with the use of the Gardner Lymphosarcoma. Proc. Amer. Ass. Cancer Res. 2, 243 (1957) (Abstr.)
Schabel, F. M.: Cellular kinetics and its implication in cancer chemotherapy in neoplasia in childhood (The University of Texas M.D. Anderson Hospital and Tumor Institute), pp. 61–78. Chicago: Year Book Medical Publishers 1969
Schabel, F. M.: Concepts for systemic treatment of micrometastases. Cancer 35, 15–24 (1975)
Sheehy, P. E., Freid, J., Winn, R., Clarkson, B. D.: Cell cycle in ovarian cancer after arabinosylcytosine. Cancer 33, 28–37 (1974)
Simpson-Herren, L., Lloyd, H. H.: Kinetic parameters and growth curves for experimental tumor systems. Cancer Chemother. Rep. 54, 143–174 (1970)
Simpson-Herren, L., Sanford, A. H., Holmquist, J. A.: Cell population kinetics of transplanted and metastatic Lewis lung carcinoma. All Tissue Kinet. 7, 349–361 (1974)
Skipper, H. E., Schabel, F. M., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. VIII. On the criteria and kinetics associated with curability of experimental leukemia. Cancer Chemother. Rep. 35, 1–111 (1964)
Tannock, I. F.: A comparison of the cell proliferation parameters in solid and ascitic Ehrlich tumors. Cancer Res. 29, 1527–1534 (1969)
Yankee, R. A., DeVita, V. T., Perry, S.: The cell cycle of leukemia L1210 cells in vivo. Cancer Res. 27, 2381–2385 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carter, S.K. Adjuvant chemotherapy for operable breast cancer with positive axillary nodes. Cancer Immunol Immunother 2, 147–150 (1977). https://doi.org/10.1007/BF00205430
Issue Date:
DOI: https://doi.org/10.1007/BF00205430